Skip to main content
Top
Published in: Journal of Neuro-Oncology 2/2014

01-09-2014 | Clinical Study

Prophylactic plastic surgery closure of neurosurgical scalp incisions reduces the incidence of wound complications in previously-operated patients treated with bevacizumab (Avastin®) and radiation

Authors: Alyssa Reiffel Golas, Tatiana Boyko, Theodore H. Schwartz, Philip E. Stieg, John A. Boockvar, Jason A. Spector

Published in: Journal of Neuro-Oncology | Issue 2/2014

Login to get access

Abstract

Neurosurgical craniotomy, craniectomy, or other trans-galeal interventions are performed for a variety of indications, including the resection of benign or malignant tumors, hematoma evacuation, and for the management of intractable seizure disorders. Despite an overall low complication rate of intervention, wound healing complications such as dehiscence, surgical site infection, and cerebrospinal fluid leak are not uncommon. A retrospective review was performed of all patients who underwent scalp incision closure at a single institution by a single plastic surgeon between 2006 and 2013. Sixty patients (83 procedures) were included in the study. Fifty-seven patients (95.0 %) underwent previous craniotomy, craniectomy, or other trans-galeal procedure. Of the total 60 patients, 35 patients received preoperative radiation. Sixteen patients received bevacizumab prior to their index case, while 12 received bevacizumab postoperatively. Ten patients (16.7 %) required additional plastic surgical intervention for wound complications after their index plastic surgery procedure. Plastic surgery was consulted prophylactically in 34 patients (38 procedures). When plastic surgery was consulted prophylactically, 4 patients (11.8 %) required further wound revision. None of the 14 patients who underwent prophylactic plastic surgery closure for previous scalp incision, preoperative bevacizumab, and XRT administration required re-intervention. Plastic surgery closure of complex scalp incisions reduces the incidence of wound complications among patients who underwent previous neurosurgical intervention, XRT administration, and preoperative bevacizumab administration. This is particularly true when plastic surgery closure is performed “prophylactically.” Further collaboration between the neurosurgical and plastic surgery teams is therefore warranted, particularly in the setting of these high-risk cases.
Literature
2.
5.
go back to reference Sughrue ME, Bloch OG, Manley GT, Stiver SI (2011) Marked reduction in wound complication rates following decompressive hemicraniectomy with an improved operative closure technique. J Clin Neurosci 18(9):1201–1205. doi:10.1016/j.jocn.2011.01.016 Sughrue ME, Bloch OG, Manley GT, Stiver SI (2011) Marked reduction in wound complication rates following decompressive hemicraniectomy with an improved operative closure technique. J Clin Neurosci 18(9):1201–1205. doi:10.​1016/​j.​jocn.​2011.​01.​016
7.
go back to reference Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27(28):4733–4740. doi:10.1200/jco.2008.19.8721 Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27(28):4733–4740. doi:10.​1200/​jco.​2008.​19.​8721
8.
go back to reference Nair S, Giannakopoulos G, Granick M, Solomon M, McCormack T, Black P (1994) Surgical management of radiated scalp in patients with recurrent glioma. Neurosurgery 34 (1):103–106; discussion 106–107. doi:10.1227/00006123-199401000-00015 Nair S, Giannakopoulos G, Granick M, Solomon M, McCormack T, Black P (1994) Surgical management of radiated scalp in patients with recurrent glioma. Neurosurgery 34 (1):103–106; discussion 106–107. doi:10.​1227/​00006123-199401000-00015
9.
go back to reference Clark AJ, Butowski NA, Chang SM, Prados MD, Clarke J, Polley MY, Sughrue ME, McDermott MW, Parsa AT, Berger MS, Aghi MK (2011) Impact of bevacizumab chemotherapy on craniotomy wound healing. J Neurosurg 114(6):1609–1616. doi:10.3171/2010.10.JNS101042 PubMedCrossRef Clark AJ, Butowski NA, Chang SM, Prados MD, Clarke J, Polley MY, Sughrue ME, McDermott MW, Parsa AT, Berger MS, Aghi MK (2011) Impact of bevacizumab chemotherapy on craniotomy wound healing. J Neurosurg 114(6):1609–1616. doi:10.​3171/​2010.​10.​JNS101042 PubMedCrossRef
11.
go back to reference Gordon CR, Rojavin Y, Patel M, Zins JE, Grana G, Kann B, Simons R, Atabek U (2009) A review on bevacizumab and surgical wound healing: an important warning to all surgeons. Ann Plast Surg 62(6):707–709. doi:10.1097/sap.0b013e3181828141 Gordon CR, Rojavin Y, Patel M, Zins JE, Grana G, Kann B, Simons R, Atabek U (2009) A review on bevacizumab and surgical wound healing: an important warning to all surgeons. Ann Plast Surg 62(6):707–709. doi:10.​1097/​sap.​0b013e3181828141​
12.
go back to reference Sharma K, Marcus JR (2012) Bevacizumab and Wound-Healing Complications: mechanisms of Action, Clinical Evidence, and Management Recommendations for the Plastic Surgeon. Ann Plast Surg. doi:10.1097/SAP.0b013e31824e5e57 Sharma K, Marcus JR (2012) Bevacizumab and Wound-Healing Complications: mechanisms of Action, Clinical Evidence, and Management Recommendations for the Plastic Surgeon. Ann Plast Surg. doi:10.​1097/​SAP.​0b013e31824e5e57​
13.
go back to reference Kasper EM, Ridgway EB, Rabie A, Lee BT, Chen C, Lin SJ (2012) Staged scalp soft tissue expansion before delayed allograft cranioplasty: a technical report. Neurosurgery 71 (1 Suppl Operative):15–20; discussion 21. doi:10.1227/neu.0b013e318242cea2 Kasper EM, Ridgway EB, Rabie A, Lee BT, Chen C, Lin SJ (2012) Staged scalp soft tissue expansion before delayed allograft cranioplasty: a technical report. Neurosurgery 71 (1 Suppl Operative):15–20; discussion 21. doi:10.​1227/​neu.​0b013e318242cea2​
14.
go back to reference Bose D, Meric-Bernstam F, Hofstetter W, Reardon DA, Flaherty KT, Ellis LM (2010) Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care. Lancet Oncol 11(4):373–382. doi:10.1016/s1470-2045(09)70341-9 Bose D, Meric-Bernstam F, Hofstetter W, Reardon DA, Flaherty KT, Ellis LM (2010) Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care. Lancet Oncol 11(4):373–382. doi:10.​1016/​s1470-2045(09)70341-9
Metadata
Title
Prophylactic plastic surgery closure of neurosurgical scalp incisions reduces the incidence of wound complications in previously-operated patients treated with bevacizumab (Avastin®) and radiation
Authors
Alyssa Reiffel Golas
Tatiana Boyko
Theodore H. Schwartz
Philip E. Stieg
John A. Boockvar
Jason A. Spector
Publication date
01-09-2014
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2014
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-014-1482-6

Other articles of this Issue 2/2014

Journal of Neuro-Oncology 2/2014 Go to the issue